Suneva Medical announced that it has amended its existing licensing agreement with Histogen to include distribution of the Regenica skincare line through the physician-dispensed channel in Europe, most of Asia, South America, Canada, Australia, and the Middle East. Suneva Medical remains the exclusive licensee in the physician-dispensed channel for Regenica in the United States.
"Regenica's growing customer base is a testament to the product's ability to rejuvenate the skin, accelerating the body's own cells' ability to repair and renew," stated Nicholas L. Teti Jr., chairman and CEO of Suneva Medical. "With this amended licensing agreement in place, international consumers will now have access to the latest U.S. growth factor technology."
